序号 | 英文名称 | 中文名称 | 标准 | CAS NO. | 用途 |
1 | Capecitabine | 卡培他滨 | USP34 | 154361-50-9 | 抗癌药 Antineoplastic Drug |
2 | 1,2,3-3-O-Acetyl-5-Deoxy-D-Ribofuranose | 三乙酰-5-脱氧核糖 | 企业标准 In-House Standard | 62211-93-2 | 卡培中间体 Capecitabine Intermediate |
3 | 2',3'-Di-O-acetyl-5'-deoxy-5-fluorocytidine | 2',3'-二乙酰基-5'-脱氧-5-氟胞苷 | 企业标准 In-House Standard | 161599-46-8 | 卡培中间体 Capecitabine Intermediate |
4 | 5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2',3'-diacetate | 5'-脱氧-5-氟-N-[(戊氧基)羰基]胞苷2',3'-二乙酸酯 | 企业标准 In-House Standard | 162204-20-8 | 卡培中间体 Capecitabine Intermediate |
5 | Atracurium Besilate | 苯磺阿曲库铵 | BP2003 USP34 EP7 | 64228-81-5 | 肌肉松弛剂 Muscle Relaxant |
6 | Atracurium Oxalate | 阿曲库铵草酸盐 | 企业标准 In-House Standard | 64228-78-0 | 苯磺阿曲库铵中间体 Atracurium Besilate Intermediate |
7 | Pentamethylene diacrylate | 戊二醇丙烯酸双酯 | 企业标准 In-House Standard | 36840-85-4 | 苯磺阿曲库铵中间体 Atracurium Besilate Intermediate |
8 | Tetrahydropapaverine HCL | 盐酸四氢罂粟碱 | 企业标准 In-House Standard | 6429-4-5 | 苯磺阿曲库铵中间体 Atracurium Besilate Intermediate |
9 | Cisatracurium Besilate | 顺苯阿曲库铵 | 企业标准 In-House Standard | 96946-42-8 | 肌肉松弛剂 Muscle Relaxant |
10 | (1R,1'R)-2,2'-(3,11-dioxatridecamethylene)-bis-(1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline)dioxalate(Cisatracurium oxalate) | (1R,1'R)-2,2'-(3,11-二氧杂-1,13-亚十三烷基)-双-[6,7-二甲氧基-1-(3,4-二甲氧基苄基)-1,2,3,4-四氢异喹啉]草酸盐(顺阿曲库铵草酸盐) | 企业标准 In-House Standard | 96687-52-4 | 顺苯磺阿曲库铵中间体 Cisatracurium Besilate Intermediate |
11 | R-Tetrahydropapaverine N-acetyl-L-leucinate | R-四氢罂粟碱N-乙酰-L-亮氨酸 | 企业标准 In-House Standard | 141109-12-8 | 顺苯磺阿曲库铵中间体 Cisatracurium Besilate Intermediate |
12 | Entecavir | 恩替卡韦 | 企业标准 In-House Standard | 142217-69-4 | 抗乙肝病毒药 Anti HBV |
13 | (1s-trans)-2-[(phenylmethoxy)methyl]-3-cyclopenten-1-ol | (1R,2S)-2-(苄氧甲基)-3-环戊烯-1-醇 | 企业标准 In-House Standard | 188399-48-6 | 恩替卡韦中间体 Entecavir intermediate |
14 | (1S,2R,3S,5R)-2-(benzyloxymethyl)-6-oxabicyclo[3.1.0]hexan-3-ol | [Is-(1a,2β,3α,5α)]-2-[(苯甲氧基)-6-氧杂二环[3.1.0]已-3-醇 | 企业标准 In-House Standard | 117641-39-1 | 恩替卡韦中间体 Entecavir intermediate |
15 | (1S,2R,3S,5R)-3-(Phenylmethoxy)-2-[(phenylmethoxy)methyl]-6-oxabicyclo[3.1.0]hexane | (1S,2R,3S,5R)-3-(苯甲氧基)-2-[(苯甲氧基)甲基]-6-氧杂双环[3.1.0]己烷 | 企业标准 In-House Standard | 110567-22-1 | 恩替卡韦中间体 Entecavir intermediate |
16 | (1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol | (1S,2S,3S,5S)-5-(2-氨基-6-苄氧基-9H-嘌呤-9-基)-3-苄氧基-2-苄氧基甲基环戊醇 | 企业标准 In-House Standard | 142217-77-4 | 恩替卡韦中间体 Entecavir intermediate |
17 | 2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]- 6-(phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanol | (2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇 | 企业标准 In-House Standard | 142217-78-5 | 恩替卡韦中间体 Entecavir intermediate |
18 | 6-(Benzyloxy)-9-((1S,3R,3S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine | 6-苄氧基-9-((1S,3R,3S)-4-苄氧基-3-苄氧基甲基-2-亚甲基环戊基)-N-((4-甲氧基苯基) 二苯基甲基)-9H-嘌呤-2-胺 | 企业标准 In-House Standard | 142217-80-9 | 恩替卡韦中间体 Entecavir intermediate |
19 | 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)- 2-methylenecyclopentyl]-6H-purin-6-one | 2-氨基-1,9-二氢-9-[(1S,3R,4S)-4-苄氧基-3-苄氧基甲基-2-亚甲基环戊基]-6H-嘌呤-6-酮 | 企业标准 In-House Standard | 142217-81-0 | 恩替卡韦中间体 Entecavir intermediate |
20 | 2-amino-9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1H-purin-6(9H)-one | 2-氨基-9-[(1S,3R,4S)-4-羟基-3-羟甲基-2-亚甲戊基]-1,9-氢-6-H-嘌呤-6-酮水合物 | 企业标准 In-House Standard | 209216-23-9 | 恩替卡韦中间体 Entecavir intermediate |
21 | Ivabradine HCL | 盐酸伊伐布雷定 | 企业标准 In-House Standard | 148849-67-6 | 心血管类药物 Cardiovascular Drug |
22 | (1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutanehydrochloride | (1S)-4,5-二甲氧基-1-[(甲基氨基)甲基]苯并环丁烷盐酸盐 | 企业标准 In-House Standard | 866783-13-3 | 盐酸伊伐布雷定主链 Ivabradine HCL Intermediate |
23 | 4,5-dimethoxy-1,2-dihydrocyclobutabenzene-1-carbonitrile | 4,5-二甲氧基-1-氰基苯并环丁烷 | 企业标准 In-House Standard | 35202-54-1 | 盐酸伊伐布雷定主链中间体 Ivabradine HCL Intermediate |
24 | 1,3-Dihydro-7,8-dimethoxy-2H-3-benzazepin-2-one | 7,8-二甲氧基-1,3-二氢-2H-3-苯并氮杂卓-2-酮 | 企业标准 In-House Standard | 73942-87-7 | 盐酸伊伐布雷定侧链中间体 Ivabradine HCL intermediate |
25 | 3-(3-Chloropropyl)-7,8-dimethoxy-1H-3-benzazepin-2(3H)-one | 3-(3-氯丙基)-1,3-二氢-7,8-二甲氧基-2H-3-苯并氮杂环庚二烯-2-酮 | 企业标准 In-House Standard | 85175-59-3 | 盐酸伊伐布雷定侧链 Ivabradine HCL Intermediate |
26 | Letrozole | 来曲唑 | USP34 | 112809-51-5 | 抗癌药 Antineoplastic Drug |
27 | Mesna | 美司钠 | EP7 | 19767-45-4 | 抗癌药 Antineoplastic Drug |
28 | 2-s-Thiuronium ethanesulfonate | 2-[(氨基亚氨基甲基)硫]乙磺酸 | 企业标准 In-House Standard | 108710-70-9 | 美司钠内盐 Mesna Inner Salt |
29 | Fludarabine Phosphate | 磷酸氟达拉滨 | USP34 | 75607-67-9 | 抗癌药 Antineoplastic Drug |
30 | Fludarabine Base | 氟达拉滨碱 | 企业标准 In-House Standard | 21679-14-1 | 氟达拉滨中间体 Fludarabine Phosphate Intermediate (N-1) |
31 | 3',5'-Di-O-acetyl-2-fluoro-2'-O-trifluoro-methanesulfonyladenosine | 3’,5’-二乙酰-2-氟-2’-三氟甲磺酰基腺苷 | 企业标准 In-House Standard | 161109-76-8 | 氟达拉滨中间体 Fludarabine Phosphate Intermediate (N-3) |
32 | 2-Fluoro-2',3',5'-Trioxo-Acetyl Adenosine | 2-氟-2',3',5'-三乙酰氧基腺苷 | 企业标准 In-House Standard | 15811-32-2 | 氟达拉滨中间体 Fludarabine Phosphate Intermediate (N-5) |
33 | 2',3',5'-tri-O-acetyl-6-chloroguanosine | 2', 3', 5'-三-O-乙酰基-6-氯鸟苷 | 企业标准 In-House Standard | 16321-99-6 | 氟达拉滨中间体 Fludarabine Phosphate Intermediate (N-7) |
34 | 2',3',5'-Triacetylguanosine | 2',3',5'-三-O-乙酰基鸟苷 | 企业标准 In-House Standard | 6979-94-8 | 氟达拉滨中间体 Fludarabine Phosphate Intermediate (N-8) |
35 | Rocuronium Bromide | 罗库溴胺 | EP6 | 119302-91-9 | 肌肉松弛剂 Muscle Relaxant |